This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: James Cassidy - Innovator in Cancer Treatment
Introduction
James Cassidy is a notable inventor based in Far Hills, New Jersey. He has made significant contributions to the field of cancer treatment through his innovative research and development efforts. His work focuses on the application of monoclonal antibodies in combination with specific compounds to enhance therapeutic outcomes for cancer patients.
Latest Patents
James Cassidy holds a patent for "Compositions and methods of treating cancer." This patent outlines methods for treating cancer in subjects using a combination of a monoclonal antibody and (R)-N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide, or a salt thereof. This innovative approach aims to improve the efficacy of cancer treatments and offers new hope for patients battling this disease. He has 1 patent to his name.
Career Highlights
James Cassidy is currently associated with Bristol-Myers Squibb Company, a leading biopharmaceutical company known for its commitment to discovering, developing, and delivering innovative medicines. His role at the company allows him to work on groundbreaking research that has the potential to change the landscape of cancer treatment.
Collaborations
Throughout his career, James has collaborated with talented professionals in the field, including Paul Andrew Basciano and Justine Kamilah Walker. These collaborations have fostered an environment of innovation and have contributed to the advancement of cancer therapies.
Conclusion
James Cassidy's work in cancer treatment exemplifies the impact of innovative thinking in the medical field. His contributions through patents and collaborations highlight the importance of research in developing effective therapies for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
